{"article_title": "Medicare Reimbursement For Lung Cancer Screening Provokes Debate", "article_keywords": ["reimbursement", "cancer", "provokes", "lung", "screening", "medicare", "debate"], "article_url": "http://www.forbes.com/sites/larryhusten/2014/10/13/medicare-reimbursement-for-lung-cancer-screening-provokes-debate/", "article_text": "", "article_metadata": {"prerender-status-code": "{{meta.code}}", "author": "Larry Husten", "og": {"site_name": "Forbes", "description": "Although 160,000 people in the U.S. die each year from lung cancer, accounting for more than a quarter of all cancer deaths, screening for lung cancer remains controversial. Based on results from the National Lung Screening Trial (NLST) in 2011, the U.S. Preventive Services Task Force (USPSTF) issued a B [...]", "title": "Medicare Reimbursement For Lung Cancer Screening Provokes Debate", "url": "http://www.forbes.com/sites/larryhusten/2014/10/13/medicare-reimbursement-for-lung-cancer-screening-provokes-debate/", "image": "http://i.forbesimg.com/media/assets/forbes_1200x1200.jpg", "updated_time": "2014-10-13T17:00:24-04:00", "type": "article"}, "twitter": {"description": "Although 160,000 people in the U.S. die each year from lung cancer, accounting for more than a quarter of all cancer deaths, screening for lung cancer remains controversial. Based on results from the National Lung Screening Trial (NLST) in 2011, the U.S. Preventive Services Task Force (USPSTF) issued a B [...]", "creator": "@@cardiobrief", "image": "http://i.forbesimg.com/media/assets/forbes_1200x1200.jpg", "title": "Medicare Reimbursement For Lung Cancer Screening Provokes Debate", "site": "@forbes", "card": "summary_large_image"}, "apple-itunes-app": "app-id=588647136", "fb": {"app_id": 123694841080850}, "keywords": "Health,Innovation and Science,Pharma and Health,healthcare,Innovation &amp; Science,Pharma &amp; Healthcare", "article": {"publisher": "https://www.facebook.com/forbes", "section_url": "http://www.forbes.com/healthcare", "section": "Pharma & Healthcare", "modified": "2014-10-13", "published": "2014-10-13", "id": "blogAndPostId/blog/post/1565-12244"}, "news_keywords": "Health,Innovation and Science,Pharma and Health,healthcare,Innovation &amp; Science,Pharma &amp; Healthcare", "viewport": "width=device-width,initial-scale=1,maximum-scale=1,user-scalable=no", "description": "Although 160,000 people in the U.S. die each year from lung cancer, accounting for more than a quarter of all cancer deaths, screening for lung cancer remains controversial. Based on results from the National Lung Screening Trial (NLST) in 2011, the U.S. Preventive Services Task Force (USPSTF) issued a B [...]"}, "_id": "\"57477af46914bd0286fda9ec\"", "article_summary": ""}